bioAffinity Technologies, Inc. Employee-related Liabilities, Current
bioAffinity Technologies, Inc. (BIAF) had Employee-related Liabilities, Current of $869.29 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Employee-related Liabilities, Current $869.29K.
- 2026-03-31: Employee-related Liabilities, Current $1.72M.
- 2025-12-31: Employee-related Liabilities, Current $1.31M.
- 2025-09-30: Employee-related Liabilities, Current $717.76K.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2026-06-30 | $869.29K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.72M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.31M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $717.76K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $776.07K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $932.21K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.08M 10-K · filed 2026-03-16 |
| 2024-09-30 | $659.29K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $749.71K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $670.49K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $857.04K 10-K · filed 2025-03-31 |
| 2023-06-30 | $276.52K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $281.08K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $340.68K 10-K · filed 2024-04-01 |
| 2022-09-30 | $231.63K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $277.19K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |